Select for export SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models Details DOI 10.1016/s0168-8278(26)01861-1 Copy citation Copy BibTeX Journal of Hepatology 2026-04-30 Anna Signor, Martina Colognesi, Giovanna Finzi, Daniela Gabbia, Andrea Mattarei, Stefano Comai OpenAlex Published psilocybin Chronic PainPharmacologyReceptor Pharmacology Animal Study Antagonism More